A promising cardiovascular treatment in a highly prevalent disease
A highly prevalent disease with existing inexpensive therapies presented a challenging pricing environment for our client’s cardiovascular treatment. To deliver the optimal pricing strategy, Inpharmation used a combination of primary and secondary pricing techniques.
Back to Case Studies
Our client wanted to understand the optimal pricing strategy…
Our client was developing a potential breakthrough in the treatment for heart failure. They wanted to understand the optimal pricing strategy across the EU5 and the USA.
...but the pricing environment was challenging
Although our client’s asset promised to deliver significant clinical benefits, there were challenges. Firstly, existing therapies were inexpensive. Secondly, heart failure is a very common condition. Both of these considerations would put downward pressure on price, so pricing was not without risk.
Our client wanted to:
- Understand the impact of clinical results from different patient subgroups.
- Inform national, regional and local pricing strategy.
- Quantify the usage in different channels:
- Specialist vs. primary care physicians.
- Retail vs. hospital.
